YPSOMED
The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of injections pens, autoinjectors and infusion systems to administer liquid drugs. Ypsomed promotes and sells its product portfolio under the umbrella brands, mylife Diabetescare directly ... to patients or through pharmacies and clinics, and under YDS Ypsomed Delivery Systems as business-to-business to pharmaceutical companies. Ypsomed has its headquarters in Burgdorf, Switzerland, and operates a global network of manufacturing sites, subsidiaries and distributors. The Ypsomed Group employs around 1400 employees.
YPSOMED
Industry:
Medical Device
Founded:
2003-01-01
Address:
Burgdorf, Bern, Switzerland
Country:
Switzerland
Website Url:
http://www.ypsomed.com
Total Employee:
1001+
Status:
Active
Contact:
+41 (0)34 424 41 22
Technology used in webpage:
Domain Not Resolving LetsEncrypt Amazon Font Awesome HSTS Nginx CrUX Top 50m Apple Mobile Web App Capable CrUX Top 10m CloudFront
Similar Organizations
Austen BioInnovation Institute
Advance Value-Added, Patient-Centered Healthcare Solutions
.
Doctor Care Anywhere
Doctor Care Anywhere is the smart, easy and convenient way to manage your health. Speak face-to-face with a doctor anytime, anywhere.
Feel Better
Feel Better is empowering patients with chronic conditions with personalized information to reduce and optimize polypharmacy.
Seno Medical Instruments
Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
Current Advisors List
Board_member
2019-01-01
Current Employees Featured
Willy Michel Chairman of the Board & Founder @ Ypsomed
Chairman of the Board & Founder
1984-01-01
Simon Michel CEO @ Ypsomed
CEO
Giovanna Davatz Senior Project Manager @ Ypsomed
Senior Project Manager
2020-09-01
Founder
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-04-13 | CeQur Simplicity | Ypsomed investment in Series C - CeQur Simplicity | 115 M USD |
Official Site Inspections
http://www.ypsomed.com Semrush global rank: 419.93 K Semrush visits lastest month: 84.82 K
- Host name: srv-a-go.c-2692.maxcluster.net
- IP address: 109.71.75.58
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Ypsomed.com lookup results from whois.corporatedomains.com server:
- Domain created: 21st-Jul-2003
- Domain updated: 17th-Jul-2024
- Domain expires: 21st-Jul-2025 0 Years, 72 Days left
- Website age: 21 Years, 293 Days
- Registrar Domain ID: 100841079_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: domainabuse@cscglobal.com
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- NS1.ITSROOT.NET
- NS2.ITSROOT.NET
More informations about "Ypsomed"
Company - Ypsomed - Canada
Feb 8, 2024 Ypsomed is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist. The company has celebrated …See details»
Group structure - Ypsomed
Mar 31, 2024 Ypsomed Holding AG is organised as a holding company pursuant to Swiss law and directly or indirectly owns or controls all the companies that form part of the Ypsomed Group worldwide. None of Ypsomed Holding AG’s …See details»
Selfcare Solutions - Ypsomed - Canada
Ypsomed Delivery Systems (YDS) provides a complete range of technologies and services for reliable and user-friendly injection systems for self-medication. Our customers are pharmaceutical and biotechnology companies that develop, …See details»
Ypsomed - Crunchbase Company Profile & Funding
The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. As a …See details»
Home - mylife Diabetescare - Canada
Ypsomed and CamDiab are pleased to announce the approval of mylife YpsoPump insulin pump and CamAPS FX hybrid closed-loop algorithm by Health Canada. This approval represents an important step in advancing diabetes …See details»
Services - Ypsomed Delivery Systems
The innovation process begins with listening to patients and the market, categorising their needs and summarising what is relevant. We utilise our direct sales channels to feel our patients’ pulses and a well-established industry …See details»
Ypsomed - Overview, News & Similar companies | ZoomInfo.com
Who is Ypsomed. Ypsomed Group is a leader in innovation and technology, they are also the is the preferred partner for pharmaceutical and biotech companies for the supply of pens, …See details»
Ypsomed Diabetescare will become mylife …
Ypsomed Diabetescare is evolving to change its brand name to mylife Diabetescare in Canada. With over 35 years of Swiss development experience behind mylife Diabetescare we are excited to align our Canadian business …See details»
Ypsomed: platform products and strategic partner networking
Ypsomed has been at the heart of the combination product ecosystem for 40 years. Ypsomed’s comprehensive pen and autoinjector platform portfolio, including UnoPen and YpsoMate, and …See details»
Ypsomed and ten23 health collaborate for the …
Apr 16, 2024 Burgdorf – Ypsomed enters a partnership with ten23 health, a global Swiss contract development and manufacturing organization. The aim of this collaboration is to advance the commercialization of the YpsoDose …See details»
Novo Nordisk said to have contracted Ypsomed to make next gen …
Novo Nordisk’s (NVO) (OTCPK:NONOF) contract with Swiss medical device maker Ypsomed (OTCPK:YPHDF) includes a deal to supply injection pens for Danish drugmaker’s next-gen …See details»
Selfcare Solutions - Ypsomed - Group
Ypsomed Delivery Systems (YDS) provides a complete range of technologies and services for reliable and user-friendly injection systems for self-medication. Our customers are …See details»
Ypsomed and CamDiab receive Health Canada approval for
Nov 7, 2024 Ypsomed is headquartered in Burgdorf, ... Organization Profile. YPSOMED CANADA INC. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact Us Become a …See details»
Ypsomed and CamDiab receive Health Canada approval for mylife …
Ypsomed’s commitment to innovation is supported by its partnerships with two leaders in diabetes technology: CamDiab developed the ever-learning and ever-adapting CamAPS FX hybrid …See details»
Corporate Strategy - Ypsomed - Group
We pursue a long-term corporate strategy. As a sustainably oriented company, we feel committed to our responsibility to society. We want to further expand our position as the world's leading …See details»
Ypsomed mylife YpsoPump Approved by Health Canada
Nov 25, 2024 The Log Book. Ypsomed mylife YpsoPump Approved by Health Canada November 25, 2024; Reducing the Burden of T1D with the MiniMed™ 780G System October …See details»
YPSOMATE ON – GO FOR SIMPLY CONNECTED
Ypsomed YPSOMATE ON – GO FOR SIMPLY CONNECTED YpsoMate On is the newest addition to Ypsomed’s connected device portfolio. It is ... World Health Organization, 2003. 3. …See details»
Ypsomed will make injection pens for Novo Nordisk's CagriSema …
Last week, Ypsomed, the world's second-largest supplier of autoinjectors by sales to the pharma industry, behind SHL Medical, said it had secured deals with 31 companies related to GLP-1 …See details»
Ypsomed Digital - mylife Diabetescare - Canada
Ypsomed Cloud access ensures data is securely stored and can be accessed from any device with an internet connection. Use the internet browser on any PC to access the Ypsomed …See details»
Vision and Mission - Ypsomed - Group
Vision. Ypsomed solutions make selfcare simpler and easier. Mission. With innovative, simple-to-use and reliable products as well as modern care concepts we contribute significantly to the …See details»